38 results on '"Jézéquel, Pascal"'
Search Results
2. Intérêt de l’outil web bc-GenExMiner en oncologie
3. Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
4. The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients
5. STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
6. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
7. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
8. A Bayesian Approach for Partial Gaussian Graphical Models With Sparsity.
9. Survivin contributes to DNA repair by homologous recombination in breast cancer cells
10. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor
11. Molecular screening of interleukin-6 gene promoter and influence of −174G/C polymorphism on breast cancer
12. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
13. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial
14. Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen
15. Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer.
16. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study
17. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2
18. Random forest of perfect trees: concept, performance, applications and perspectives.
19. A partial graphical model with a structural prior on the direct links between predictors and responses.
20. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1
21. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
22. Gene-expression signature functional annotation of breast cancer tumours in function of age.
23. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
24. Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.
25. Automatic Segmentation of Metastatic Breast Cancer Lesions on 18 F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment.
26. bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
27. Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy.
28. Molecular screening of the gene in men with anomalies of the vas deferens: identification of three novel mutations.
29. iTRAQ‐Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple‐Negative Breast Cancer Tumors.
30. OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH‐Based Proteomic Approach.
31. Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
32. BP67 - Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304).
33. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
34. French CF family genotype analysis shows that the R297Q mutation is a rare polymorphism.
35. Haemochromatosis and HLA-H.
36. Identification of a novel mutation (A268G) in exon 8 of the HTRβ gene in a large family with thyroid hormone resistance.
37. Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation.
38. Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1--Dependent Repression of BMP-5.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.